Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
1.
Heart Fail Rev ; 29(5): 957-967, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38940991

RESUMEN

Heart failure imposes a significant global health burden, standing as a primary contributor to mortality. Various indicators and physiological shifts within the body may hint at distinct cardiac conditions. Specific biosensors have the capability to identify these changes. Integrating or embedding these biosensors into mechanical circulatory support devices (MCSDs), such as left ventricular assist devices (LVADs), becomes crucial for monitoring alterations in biochemical and physiological factors subsequent to an MCSD implantation. Detecting abnormal changes early in the course of disease progression will allow for improved patient outcomes and prognosis following an MCSD implantation. The aim of this review is to explore the available biosensors that may be coupled or implanted alongside LVADs to monitor biomarkers and changes in physiological parameters. Different fabrication materials for the biosensors are discussed, including their advantages and disadvantages. This review also examines the feasibility of integrating feedback control mechanisms into LVAD systems using data from the biosensors. Challenges facing this emerging technology and future directions for research and development are outlined as well. The overarching goal is to provide an overview of how implanted biosensors may improve the performance and outcomes of LVADs through continuous monitoring and closed-loop control.


Asunto(s)
Técnicas Biosensibles , Insuficiencia Cardíaca , Corazón Auxiliar , Humanos , Técnicas Biosensibles/métodos , Técnicas Biosensibles/instrumentación , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/terapia , Insuficiencia Cardíaca/fisiopatología , Biomarcadores
2.
Phys Med ; 83: 206-220, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33940342

RESUMEN

In recent years enterprise imaging (EI) solutions have become a core component of healthcare initiatives, while a simultaneous rise in big data has opened up a number of possibilities in how we can analyze and derive insights from large amounts of medical data. Together they afford us a range of opportunities that can transform healthcare in many fields. This paper provides a review of recent developments in EI and big data in the context of medical physics. It summarizes the key aspects of EI and big data in practice, with discussion and consideration of the steps necessary to implement an EI strategy. It examines the benefits that a healthcare service can achieve through the implementation of an EI solution by looking at it through the lenses of: compliance, improving patient care, maximizing revenue, optimizing workflows, and applications of artificial intelligence that support enterprise imaging. It also addresses some of the key challenges in enterprise imaging, with discussion and examples presented for those in systems integration, governance, and data security and privacy.


Asunto(s)
Inteligencia Artificial , Diagnóstico por Imagen , Macrodatos , Humanos , Física , Flujo de Trabajo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA